Results 151 to 160 of about 10,116 (213)

Botulinum Toxin in Children and Adolescents-A Comprehensive Review of Clinical Applications. [PDF]

Toxins (Basel)
Bašković M, Nikić Čižmek V, Buzuk J, Dujić B, Jurić D, Jurković K, Pehar K, Vuković S.   +7 more
europepmc   +1 more source

Muscle-Specific Dosing of OnabotulinumtoxinA in Post-Stroke Upper-Limb Spasticity: A Descriptive Literature Review. [PDF]

Toxins (Basel)
Cisowska-Adamiak M, Mackiewicz-Milewska M, Miller ED.   +2 more
europepmc   +1 more source

Botulinum Toxin as Targeted Neuromodulation in Complex Regional Pain Syndrome: An Anatomy-Informed Mechanistic Review. [PDF]

Toxins (Basel)
Suputtitada A.
europepmc   +1 more source

Multimodal Rehabilitation with Focal Vibration After Botulinum Toxin Injection in Ambulatory Children with Cerebral Palsy: A Proof-of-Concept Pilot Study. [PDF]

Toxins (Basel)
Picelli A, Di Censo R, Di Maria I, Vangelista A, Benetti MV, Smania N, Varalta V, Filippetti M.   +7 more
europepmc   +1 more source

Laboratory Diagnostics of Botulism Cases in Livestock in Poland in 2022-2024. [PDF]

Pathogens
Jarosz A, Sapała M, Grenda T.
europepmc   +1 more source

The Impact of OnabotulinumtoxinA on Oral Pain Medication Prescription Fills and Low-Value Care in Patients with Cervical Dystonia in the United States: A Retrospective Claims Analysis. [PDF]

Toxins (Basel)
Rhyne C, Dominguez A, Cheng N, Manthena S, Parikh K, Jabbari B.   +5 more
europepmc   +1 more source

Design and Characterization of Recombinant and Chimeric BoNT/A Neurotoxins with Receptor-Binding Domain Grafting. [PDF]

Toxins (Basel)
Pan S, Ye Y, Li Y, Fu H, Wang J.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Clinical use of non-a botulinum toxins: Botulinum toxin type C and botulinum toxin type F

Neurotoxicity Research, 2006
Botulinum neurotoxin (BoNT) serotype A is commonly used in the treatment of focal dystonia, but some patients are primarily or become secondarily resistant to it. Consequently, other serotypes have to be used when immuno-resistance is proven. In the literature, patients with focal dystonia have been treated with BoNT serotype F with clinical benefit ...
ELEOPRA R, TUGNOLI V, QUATRALE R, ROSSETTO, ORNELLA, MONTECUCCO, CESARE, DRESSLER D.   +5 more
openaire   +3 more sources

Complications of Botulinum Toxin Type A

Facial Plastic Surgery Clinics of North America, 2007
Introduced over 30 years ago for the treatment of strabismus and blepharospasm, botulinum toxin type A (BTX-A) now has established uses for various therapeutic and cosmetic purposes. Although remarkably safe and effective, BTX-A is a potent toxin. Complications can occur, particularly when used by the inexperienced injectors.
Jean, Carruthers, Alastair, Carruthers
openaire   +2 more sources